§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US5061237A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of purifying whole blood

Assignee: OMNI MEDICAL Ltd
•
Filing: 1989-10-11
•
Granted: 1991-10-29
•
Expires: 2009-10-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A medical device, particularly a filter, cannula, catheter, or implant made of plastic or plastic-coated metal or glass for fixing disease-causing microorganisms, particularly viruses, bacteria, and fungi as well as pathogenic metabolic products, toxins, lipoid substances, and drugs, wherein the plastic surface is provided (firmly attached thereto or covalently bound therewith): a) homologous or monoclonal immunoglobulins, preferably those that have been afterpurified by affinity chromatography in the classes G1, G2, G3, and/or G4 and/or IGM, IGE, IGD and/or IGA and/or the F(ab)2 fragments thereof, preferably those that have been afterpurified by affinity chromatography, which are selectively active against the specific antigens or antigenic determinants of the respective disease-causing microorganisms, particularly viruses, bacteria, and fungi as well as pathogenic metabolic products, toxins, lipoid substances (e.g., lipids), and drugs, or b) gamma globulins, particularly heterologous gamma globulins, which are active against the most widely differing antigens or antigenic determinants of the disease-causing microorganisms concerned, particularly viruses, bacteria, and fungi.

Inventors

  • 👤 Reiner Gessler
  • 👤 Manfred Rycyk

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:19
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/0043; A61M25/0045; A61L; A61L29/00; A61L29/14; A61L29/16; A61M1/00; A61M1/36; A61M1/3687; A61L2300/00; A61L2300/20; A61L2300/252; A61L2300/256

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 92 words
A method for purifying whole blood which comprises contacting whole blood containing a pathogenic microorganism or a metabolic product of a pathogenic microorganism with a plastic surface having attached thereto F(ab) 2 fragments from a homologous or monoclonal immunoglobulin selectively active against a specific antigen or antigenic determinant of the pathogenic microorganism or the metabolic product of the pathogenic microorganism, wherein the F(ab) 2 fragments are free of Fc fragments, to separate the pathogenic microorganism or the metabolic product of the pathogenic microorganism from the whole blood contacted with said plastic surface.
Claim 2
Independent Claim 92 words
A method for purifying whole blood which comprises contacting whole blood containing a pathogenic microorganism or a metabolic product of a pathogenic microorganism with a plastic surface having attached thereto F(ab) 2 fragments from a homologous or monoclonal immunoglobulin selectively active against a specific antigen or antigenic determinant of the pathogenic microorganism or the metabolic product of the pathogenic microorganism, wherein the F(ab) 2 fragments are free of Fc fragments, to separate the pathogenic microorganism or the metabolic product of the pathogenic microorganism from the whole blood contacted with said plastic surface.
Claim 3
Dependent Claim 18 words
A method according to claim 1, wherein the F(ab) 2 fragments are covalently bound to the plastic surface.
Claim 4
Dependent Claim 43 words
A method according to claim 1, wherein the F(ab) 2 fragments were obtained by enzymatically cleaving the immunoglobulin to form F(ab) 2 and Fc fragments and wherein the Fc fragments were separated before the F(ab) 2 fragments were attached to the plastic surface.
Claim 5
Dependent Claim 24 words
A method according to claim 1, wherein the immunoglobulin is at least one of G1, G2, G3, G4, IGM, IGE, IGD or IGA immunoglobulin.
Claim 6
Independent Claim 90 words
A method for purifying whole blood which comprises: a) withdrawing whole blood containing a pathogenic microorganism or a metabolic product of a microorganism from a body, b) contacting the whole blood removed from the body with a plastic surface having attached thereto F(ab) 2 fragments, from which the Fc fragments have been separated, of a homologous or monoclonal immunoglobulin selectively active against a specific antigen or antigenic determinant of the pathogenic microorganism or the metabolic product of the microorganism, and c) returning the thus contacted whole blood to the body.
Claim 7
Independent Claim 90 words
A method for purifying whole blood which comprises: a) withdrawing whole blood containing a pathogenic microorganism or a metabolic product of a microorganism from a body, b) contacting the whole blood removed from the body with a plastic surface having attached thereto F(ab) 2 fragments, from which the Fc fragments have been separated, of a homologous or monoclonal immunoglobulin selectively active against a specific antigen or antigenic determinant of the pathogenic microorganism or the metabolic product of the microorganism, and c) returning the thus contacted whole blood to the body.

References Cited (Backward Citations)

US4279885A Cited
US4292403A Cited
US4374925A Cited
US4272504A Cited
JPS56151357A Cited
JPS5758947A Cited
US4425438A Cited
JPS57170263A Cited
US4478946A Cited
EP0082345A1 Cited
US4664913B1 Cited
US4664913A Cited
US4624930A Cited
EP0109531A1 Cited
US4634417A Cited
JPS59139936A Cited
EP0132534A2 Cited
US4552839A Cited
EP0138297A1 Cited
US4632901A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-10-28 1995-04-29 1995-10-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-10-28 1999-04-29 1999-10-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-10-28 2003-04-29 2003-10-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag